These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2946497)

  • 1. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
    Antonen J; Krohn K
    Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological findings associated with HTLV-III antibody positivity.
    Antonen J
    Ann Clin Res; 1985; 17(2):81-5. PubMed ID: 2994542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
    Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
    Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
    Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
    Clerici M; Wynn TA; Berzofsky JA; Blatt SP; Hendrix CW; Sher A; Coffman RL; Shearer GM
    J Clin Invest; 1994 Feb; 93(2):768-75. PubMed ID: 8113410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.
    Lane HC; Depper JM; Greene WC; Whalen G; Waldmann TA; Fauci AS
    N Engl J Med; 1985 Jul; 313(2):79-84. PubMed ID: 2582258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders.
    Prince HE; John JK
    Clin Exp Immunol; 1987 Jan; 67(1):59-65. PubMed ID: 2957130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
    Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
    Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
    J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
    Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
    Prince HE; Kermani-Arab V; Fahey JL
    J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells.
    Swain SL; McKenzie DT; Weinberg AD; Hancock W
    J Immunol; 1988 Nov; 141(10):3445-55. PubMed ID: 2972774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 production and response by helper T-cell subsets in man.
    Salmon M; Kitas GD; Gaston JS; Bacon PA
    Immunology; 1988 Sep; 65(1):81-5. PubMed ID: 2972603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.